Well Lead Medical Co., Ltd. (SHA:603309)
China flag China · Delayed Price · Currency is CNY
15.01
+0.15 (1.01%)
At close: Feb 13, 2026

Well Lead Medical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
301287.64302.87393.02604.58161.85
Trading Asset Securities
128.05192.62144.08310.9430.19-
Cash & Short-Term Investments
429.06480.26446.95703.96634.77161.85
Cash Growth
0.39%7.45%-36.51%10.90%292.19%-6.24%
Accounts Receivable
245.96209.81190.2696.22134.0196.29
Other Receivables
12.69.9911.889.749.9211.15
Receivables
258.57219.79202.14105.96143.93107.44
Inventory
196.18168.61143.04163.03168.31133.45
Prepaid Expenses
-0.090.17.710.065.1
Other Current Assets
19.6717.3125.1613.4627.4727.1
Total Current Assets
903.47886.06817.39994.11974.54434.94
Property, Plant & Equipment
743.35653.66848.2594.29581.78472.07
Long-Term Investments
132.11170.18270.67130.3848.9171.29
Goodwill
292.53292.53292.53292.53292.53292.53
Other Intangible Assets
173.43181.71167.74172.99182.89156.24
Long-Term Deferred Tax Assets
6.967.4713.4912.847.515.53
Long-Term Deferred Charges
27.5622.1524.9920.556.745.62
Other Long-Term Assets
628.34626.91170.26165.937.4550.55
Total Assets
2,9082,8412,6052,3842,1321,489
Accounts Payable
182.05218.83158.7178.63112.8387.89
Accrued Expenses
38.66104.03110.4588.4172.1171.51
Short-Term Debt
170.1110.0790.07115.8295.94-
Current Portion of Long-Term Debt
32.0214.394.520.0550.1350.17
Current Portion of Leases
-5.285.657.16.48-
Current Income Taxes Payable
26.629.9511.69.968.654.5
Current Unearned Revenue
29.336.4530.7645.8131.9319.88
Other Current Liabilities
30.2932.7829.4431.6148.484.73
Total Current Liabilities
509.03531.79441.2477.38426.55238.68
Long-Term Debt
370.03349.01268.65104.4257.0384
Long-Term Leases
54.8929.4528.1932.635.03-
Long-Term Unearned Revenue
14.0916.118.8118.5416.715.81
Long-Term Deferred Tax Liabilities
12.4911.2711.5210.915.576.33
Total Liabilities
960.53937.61768.37643.85540.87344.83
Common Stock
291.87292.87293.16293.32293.42260
Additional Paid-In Capital
638.83644.82650.73651.73633.04247.77
Retained Earnings
1,007960.12904.87812.04685.05632.95
Treasury Stock
--6.36-8.24-14.49-24.22-
Comprehensive Income & Other
-2.21-6.47-23.43-18.73-8.82-6.55
Total Common Equity
1,9351,8851,8171,7241,5781,134
Minority Interest
11.9318.119.8215.8913.019.78
Shareholders' Equity
1,9471,9031,8371,7401,5911,144
Total Liabilities & Equity
2,9082,8412,6052,3842,1321,489
Total Debt
627.04508.2397.08260244.62134.17
Net Cash (Debt)
-197.98-27.9449.87443.96390.1527.68
Net Cash Growth
---88.77%13.79%1309.49%-
Net Cash Per Share
-0.67-0.100.171.521.510.11
Filing Date Shares Outstanding
292.87292.87293.16293.32293.42260
Total Common Shares Outstanding
292.87292.87293.16293.32293.42260
Working Capital
394.44354.28376.19516.73547.99196.26
Book Value Per Share
6.616.446.205.885.384.36
Tangible Book Value
1,4691,4111,3571,2581,103685.39
Tangible Book Value Per Share
5.024.824.634.293.762.64
Buildings
-393.75429.34393.32379.99373.55
Machinery
-371.44343.97307.39283.76250.62
Construction In Progress
-128.62326.75108.2390.1430.46
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.